Germany 100% owned Portfolio

AMP GmbH

EU-licensed pharmaceutical wholesale distributor.

1.3 t
Medical cannabis flower distributed in Q1 2026
9
GMP-qualified suppliers across 3 countries
GMP + GDP
Full EU pharmaceutical licensing
About

A fully licensed EU pharmaceutical distributor focused on medical cannabis.

AMP GmbH is a fully licensed EU pharmaceutical distributor focused on medical cannabis. AMP holds GMP (Manufacturer Approval, GMP1 scope) and GDP licences for regulated medicinal products, including EU-market medical cannabis.

AMP acts as importer, manufacturer and QP-release pharma partner, runs GDP-compliant warehousing and temperature-controlled logistics, and provides a B2B managed-service stack to Marketing Authorisation Holders and off-takers across designated EU countries.

Capability

End-to-end compliance as a single counterparty.

Licences
GMP (Manufacturer Approval, GMP1 scope) · GDP
GMP suppliers
9 qualified suppliers across Thailand, Czech Republic and Denmark
Services
Import · Manufacture · QP-release · GDP distribution
Storage
GDP-compliant warehousing, temperature-controlled
Target market
MAHs and off-takers across designated EU countries
Domicile
Germany
What this position delivers

Three structural advantages in Europe’s largest medical cannabis market.

01

A regulated channel into Germany

Direct access to the largest medical cannabis market in Europe, through a fully licensed distribution entity with existing GMP and GDP approvals.

02

End-to-end compliance

A single counterparty for import, manufacture and QP-release — eliminating the need for multiple separate regulatory relationships.

03

Group integration

AMP serves as the German distribution channel for cannabis produced by other Essence portfolio companies, creating direct group-level synergies.

A regulated industry deserves a regulated investor.

Essence Investment AG · Switzerland

Get in touch